Cyclacel Pharmaceuticals to Present at the 19th Annual BIO CEO & Investor Conference
Feb 06, 2017 12:00 pm UTC| Business
BERKELEY HEIGHTS, N.J., Feb. 06, 2017 -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases of...
uniQure Announces Presentations at Upcoming February Conferences
Feb 06, 2017 12:00 pm UTC| Business
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Feb. 06, 2017 -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced presentations at the following conferences taking place in February: Leerink...
Feb 06, 2017 12:00 pm UTC| Business
SANTA MONICA, Calif., Feb. 06, 2017 -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders,...
IRADIMED CORPORATION Announces Fourth Quarter 2016 Financial Results
Feb 06, 2017 12:00 pm UTC| Business
Reports fourth quarter 2016 revenue of $6.0 millionReports fourth quarter 2016 GAAP diluted EPS of $0.10 and non-GAAP diluted EPS of $0.11 WINTER SPRINGS, Fla., Feb. 06, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD),...
Feb 06, 2017 12:00 pm UTC| Business
YAVNE, Israel, Feb. 06, 2017 -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces that the...
Informatica Launches Global Channel Partner Program
Feb 06, 2017 12:00 pm UTC| Business
Redwood City, Feb. 06, 2017 -- As part of its strategy to provide organizations the ability to use data to empower their business, InformaticaÒ, the world’s No. 1 provider ofdata management solutions, today announced...
Sunesis Pharmaceuticals to Present at the 19th Annual BIO CEO & Investor Conference
Feb 06, 2017 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 06, 2017 -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will present at the 19th Annual BIO CEO Investor...